SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-149039
Filing Date
2005-07-26
Accepted
2005-07-26 16:46:34
Documents
6
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 411085
2 FORM OF STOCK OPTION GRANT AGREEMENT UNDER THE 2005 OMNIBUS INCENTIVE PLAN dex101.htm EX-10.1 33571
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 10029
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 10591
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex32.htm EX-32 7047
6 GRAPHIC g94411image001.jpg GRAPHIC 7353
  Complete submission text file 0001193125-05-149039.txt   483922
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23272 | Film No.: 05974685
SIC: 2836 Biological Products, (No Diagnostic Substances)